Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: managed-care experience

By Willke Richard J.   Zhou Steve   Vogel Robert A.  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2873-2882

Informa Healthcare

Access to resources Recommend Favorite

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study

By Foody JoAnne M.   Joyce Amie T.   Rudolph Amy E.   Liu Larry Z.   Benner Joshua S.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1987-2000

Informa Healthcare

Access to resources Recommend Favorite

Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia

By Paragh G.   Törőcsik D.   Seres I.   Harangi M.   Illyés L.   Balogh Z.   Kovács P.  

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1321-1327

Informa Healthcare

Access to resources Recommend Favorite

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

By Assmann Gerd   Kannenberg Frank   Ramey Dena R.   Musliner Thomas A.   Gutkin Stephen W.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 249-259

Informa Healthcare

Access to resources Recommend Favorite

Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients

By Hadjibabaie Molouk   Gholami Kheirollah   Khalili Hossain   Khoei Seyed Hamid   Nakhjavani Manoochehr   Rayati Kobra   Tohidi Atefeh   Rahimi Roja   Abdollahi Mohammad  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 759-764

Future Medicine

Access to resources Recommend Favorite